Clinical Trial

GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study

Study acronym: GLAUDIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to identify early diagnostic markers of glaucomatous damage by combining functional and structural assessments. Patients with primary open-angle glaucoma and ocular hypertension will undergo comprehensive ophthalmological evaluation, including visual field testing and multimodal imaging of the optic nerve and retina. Both retrospective and prospective data will be collected. The main objective is to define new diagnostic paradigms for detecting early glaucomatous changes and to improve the accuracy of current clinical practice in glaucoma management.
Trial Details
NCT Number NCT07210216
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Glaucoma Open-Angle Primary, Ocular Hypertension
Enrollment 60 participants
Start Date 2025-10
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-10-07